Profile
| Metric | Value |
|---|---|
| Full Name | Sangamo Therapeutics, Inc. |
| Ticker | NASDAQ: SGMO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sangamo.com |
| Employees | 183 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.45 | |
| Price, 1D Change | +2.27% | |
| $151M | ||
| - | ||
| - | ||
| 1.22 | ||
| $58M | ||
| Revenue, 1Y Change | -67.20% | |
| -$0.49 | ||
| EPS, 1Y Change | +67.14% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.49 | ||
| EPS Estimate | -$0.41 | |
| EPS Est. Change | +15.57% | |
| $57.80M | ||
| Revenue Estimate | $65.55M | |
| Revenue Est. Change | +13.41% | |
| Current Price | $0.45 | |
| Price Target | - | $2.00 |
| Price Tgt. Change | - | +344.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.38 | -$1.48 | -7.10% | |
| - | -$0.49 | - | |
| -$0.41 | N/A | +15.57% | |
| -$0.23 | N/A | +52.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $183.00M | $176.23M | -3.70% | |
| $62.02M | $57.80M | -6.81% | |
| $65.55M | N/A | +13.41% | |
| $55.38M | N/A | -4.20% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.45 | |
| $0.55 | ||
| SMA 200 vs Price | +23.02% | |
| $0.46 | ||
| SMA 50 vs Price | +2.62% | |
| 1.22 | ||
| $0.03 | ||
| 49.30 | ||
| 54.59% | ||
| 95.50% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $57.80M | ||
| -$0.49 | ||
| $48.44M | ||
| 83.80% | ||
| -$98.45M | ||
| -170.33% | ||
| -$97.94M | ||
| -169.45% | ||
| -$98.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 1.13 | ||
| 1.13 | ||
| - | ||
| 2 | ||
| -21.37 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.61 | ||
| 24.25 | ||
| -1.43 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $22.77M | ||
| $41.92M | ||
| $105.31M | ||
| $51.69M | ||
| $82.54M | ||
| $45.81M | ||
| $30.57M | ||
| $4.31M | ||
| $15.49M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $156.25M | ||
| $156.25M | ||
| $9.36M | ||
| $44.73M | ||
| $9.36M | ||
| $0.00 | ||
| -$167.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$67.14M | ||
| $37.52M | ||
| $28.38M | ||
| $267.00K | ||
| -$67.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with SGMO
Data Sources & References
- SGMO Official Website www.sangamo.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1001233/000100123325000024/0001001233-25-000024-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1001233/000162828025013088/0001628280-25-013088-index.htm
- SGMO Profile on Yahoo Finance finance.yahoo.com/quote/SGMO
- SGMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgmo
FAQ
What is the ticker symbol for Sangamo Therapeutics, Inc.?
The ticker symbol for Sangamo Therapeutics, Inc. is NASDAQ:SGMO
Does Sangamo Therapeutics, Inc. pay dividends?
No, Sangamo Therapeutics, Inc. does not pay dividends
What sector is Sangamo Therapeutics, Inc. in?
Sangamo Therapeutics, Inc. is in the Healthcare sector
What industry is Sangamo Therapeutics, Inc. in?
Sangamo Therapeutics, Inc. is in the Biotechnology industry
What country is Sangamo Therapeutics, Inc. based in?
Sangamo Therapeutics, Inc. is headquartered in United States
When did Sangamo Therapeutics, Inc. go public?
Sangamo Therapeutics, Inc. initial public offering (IPO) was on April 6, 2000
Is Sangamo Therapeutics, Inc. in the S&P 500?
No, Sangamo Therapeutics, Inc. is not included in the S&P 500 index
Is Sangamo Therapeutics, Inc. in the NASDAQ 100?
No, Sangamo Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Sangamo Therapeutics, Inc. in the Dow Jones?
No, Sangamo Therapeutics, Inc. is not included in the Dow Jones index
When was Sangamo Therapeutics, Inc. last earnings report?
Sangamo Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Sangamo Therapeutics, Inc. report earnings?
The next expected earnings date for Sangamo Therapeutics, Inc. is March 16, 2026